Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy

Open Label, Randomized, Comparative, Single Center, Pilot Study to Assess the Added Value of inReach Technology Software on Performance Characteristics of Standard Bronchoscopy.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00817167

Enrollment

Registered

2009-01-06

Start date

2009-01-31

Completion date

2009-12-31

Last updated

2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Disease

Keywords

Known or suspected lung disease, Candidates for non-emergency bronchoscopy

Brief summary

The study is aimed to evaluate and describe the added value of inReach planning software on performance characteristics of standard bronchoscopy.

Interventions

DEVICEinReach bronchoscopy planning software

inReach planning software creates three-dimensional lung CT reconstruction, enabling rapid virtual endoscopic depiction of the airways that allows to plan bronchoscopy virtually.

DEVICEStandard lung CT viewer

CT viewer, used for standard bronchoscopy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Candidates for non-emergency bronchoscopy * Must provide signed informed consent * Male or female above 18 years old * Lung lesions up to 3 cm in size (in largest diameter), non-visible by standard bronchoscope

Exclusion criteria

* CT done over a month before the bronchoscopy procedure

Design outcomes

Primary

Measure	Time frame
Bronchoscopy Diagnostic Yield, compared between two study groups and calculated as percentage of true diagnoses from total number of bronchoscopy procedures.	Until the definitive diagnosis is obtained

Secondary

Measure	Time frame
Bronchoscopy Safety Profile, compared between two groups and calculated as percentage of bronchoscopy-related adverse events.	At discharge from bronchoscopy unit

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026